Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Poser

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Geburtshilfe Und Frauenheilkunde|May 1, 1981
[Endocrinological findings in patients with multiple sclerosis (author's transl)]S Poser, K Kreikenbaum, A König, et al.
Clinical Orthopaedics and Related Research|January 26, 1999
Potential role of fibroblast growth factor in enhancement of fracture healingM L Radomsky, A Y Thompson, R C Spiro, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|February 17, 1999
Chronic manganism: fourteen years of follow-upS Bleich, D Degner, R Sprung, et al.
The Journal of Biological Chemistry|December 27, 1996
Differential regulation of type I and type VIII Ca2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivoM D Nielsen, G C Chan, S W Poser, et al.
Der Nervenarzt|June 10, 2000
[Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings]D Degner, S Bleich, A Riegel, et al.
Diabetologia|July 1, 1976
Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran)H G Joost, J Beckmann, S Holze, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1976
Characterization of a gamma-carboxyglutamic acid-containing protein from boneP A Price, A A Otsuka, J W Poser, et al.
Acta Neurologica Scandinavica|November 1, 1986
Prognostic indicators in multiple sclerosisS Poser, W Poser, G Schlaf, et al.
Acta Neuropathologica|April 20, 2001
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brainA L Sirén, F Knerlich, W Poser, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1997
OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approachH Ehrenreich, A Mangholz, M Schmitt, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Geburtshilfe Und Frauenheilkunde|May 1, 1981
[Endocrinological findings in patients with multiple sclerosis (author's transl)]S Poser, K Kreikenbaum, A König, et al.
Clinical Orthopaedics and Related Research|January 26, 1999
Potential role of fibroblast growth factor in enhancement of fracture healingM L Radomsky, A Y Thompson, R C Spiro, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|February 17, 1999
Chronic manganism: fourteen years of follow-upS Bleich, D Degner, R Sprung, et al.
The Journal of Biological Chemistry|December 27, 1996
Differential regulation of type I and type VIII Ca2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivoM D Nielsen, G C Chan, S W Poser, et al.
Der Nervenarzt|June 10, 2000
[Follow-up study after enteral manganese poisoning: clinical, laboratory and neuroradiological findings]D Degner, S Bleich, A Riegel, et al.
Diabetologia|July 1, 1976
Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran)H G Joost, J Beckmann, S Holze, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1976
Characterization of a gamma-carboxyglutamic acid-containing protein from boneP A Price, A A Otsuka, J W Poser, et al.
Acta Neurologica Scandinavica|November 1, 1986
Prognostic indicators in multiple sclerosisS Poser, W Poser, G Schlaf, et al.
Acta Neuropathologica|April 20, 2001
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brainA L Sirén, F Knerlich, W Poser, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1997
OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approachH Ehrenreich, A Mangholz, M Schmitt, et al.
Pageof 13